Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 18, 2023

Impact of a Bone-Targeted Therapy Regimen on Skeletal-Related Events in Patients With MBC and Bone Metastasis Surviving Longer Than 2 Years

Clinical Breast Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Breast Cancer
Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer than 2 Years with Metastatic Breast Cancer and Bone Metastasis
Clin. Breast Cancer 2023 Aug 29;[EPub Ahead of Print], A Jayan, AS Raghavendra, R Bassett, et al

Further Reading